Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
Thyroid. 2013 Aug;23(8):947-54. doi: 10.1089/thy.2012.0471. Epub 2013 Jul 17.
Triiodothyronine (T3) has many effects on the heart, and marked changes in cardiac function and structure occur in patients with (subclinical) thyroid disease. We investigated whether between-subject variation in thyroid hormone levels within the euthyroid range is also associated with heart rate and echocardiographic heart function and structure.
Subjects were selected from the Asklepios study (n=2524), a population-representative random sample of patients aged between 35 and 55 years, free from overt cardiovascular disease at baseline. Analyses were restricted to 2078 subjects (1013 women and 1065 men), not using antihypertensive or thyroid medication nor having antithyroperoxidase antibody levels above clinical cut-off or thyrotropin (TSH) levels outside the reference range. All subjects were phenotyped in-depth and underwent comprehensive echocardiography, including diastolic evaluation. Thyroid function parameters were determined by automated electrochemiluminescence.
Heart rate was robustly positively associated with (quartiles of) free T3 (FT3) and T3, both in subjects with TSH levels within reference (0.27-4.2 μU/L) and in narrow TSH range (0.5-2.5 μU/L; p<0.0001). FT3 and T3 were negatively associated with left ventricular (LV) end-diastolic volume but positively associated with relative wall thickness. Total T3 (TT3) was associated with enhanced ventricular contraction (as assessed by tissue Doppler imaging). Free thyroxine, FT3, and TT3 were positively associated with late ventricular filling, and TT3 was associated with early ventricular filling.
We have demonstrated a strong positive association between thyroid hormone levels within the euthyroid range and heart rate, and more subtle effects on cardiac function and structure. More specifically, we suggest a smaller LV cavity size (with increased relative wall thickness), an enhanced atrial and ventricular contraction, and LV relaxation with higher circulating thyroid hormones. These results illustrate that variation in thyroid hormone levels, even within the reference range, exerts effects on the heart.
三碘甲状腺原氨酸(T3)对心脏有多种影响,亚临床甲状腺疾病患者的心脏功能和结构会发生明显变化。我们研究了甲状腺激素水平在正常范围内的个体间变化是否也与心率以及超声心动图心功能和结构有关。
该研究从 Asklepios 研究中选取了受试者(n=2524),这是一项针对 35 至 55 岁人群的代表性随机样本研究,在基线时没有明显的心血管疾病。分析仅限于 2078 名受试者(1013 名女性和 1065 名男性),这些受试者未使用抗高血压药物或甲状腺药物,抗甲状腺过氧化物酶抗体水平未超过临床截止值,促甲状腺激素(TSH)水平也在参考范围内。所有受试者都进行了深入的表型分析,并进行了全面的超声心动图检查,包括舒张期评估。甲状腺功能参数通过自动化电化学发光法确定。
在 TSH 水平在参考范围内(0.27-4.2μU/L)和狭窄 TSH 范围内(0.5-2.5μU/L)的受试者中,心率与游离三碘甲状腺原氨酸(FT3)和 T3(四分位数)均呈明显正相关(p<0.0001)。FT3 和 T3 与左心室(LV)舒张末期容积呈负相关,但与相对壁厚度呈正相关。总三碘甲状腺原氨酸(TT3)与组织多普勒成像评估的心室收缩增强有关。游离甲状腺素、FT3 和 TT3 与晚期心室充盈呈正相关,TT3 与早期心室充盈呈正相关。
我们证明了甲状腺激素水平在正常范围内与心率之间存在很强的正相关,并且对心脏功能和结构的影响更为微妙。具体来说,我们认为较高的循环甲状腺激素水平与较小的 LV 腔大小(伴有相对壁厚度增加)、心房和心室收缩增强以及 LV 舒张有关。这些结果表明,即使在参考范围内,甲状腺激素水平的变化也会对心脏产生影响。